Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JM Integrated Health vs MyFastRx

JM Integrated Health
Graded #428

Lower grade

vs+11.500000000000007
MyFastRx
Graded #172

Higher grade

The verdict

MyFastRx takes it — 67.4/100 to 55.9/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +30
45
75
Dose & formulationMyFastRx +19
53
72
Clinical oversightJM Integrated Health +23
89
66
Labs & monitoringJM Integrated Health +1
53
52
FulfillmentMyFastRx +27
56
83
Contract termsMyFastRx +21
20
41
JM Integrated Health · left barMyFastRx · right bar

The numbers

MetricJM Integrated HealthMyFastRx
WeighScore55.9/10067.4/100
GradeCC
Scorecard rank#428#172
SemaglutideNot disclosed$169/mo
TirzepatideNot disclosed$249/mo
Coverage6 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
JM Integrated Health

Graded #428 · C

Strengths

  • Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
  • Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
  • Six states clearly listed (TX, VT, NM, AZ, WA, NV)
  • Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
  • Publishes the FDA compounded-medication disclaimer

Where it loses points

  • 503A pharmacy partner not named publicly
  • Single-provider practice — enrollment is capacity-limited
  • Only six states served, vs nationwide competitors
  • Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
  • No LegitScript certification displayed
MyFastRx

Graded #172 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard